PREVENTION, rather than cure could become the norm in the West if modern biotechnology has its way. Several big multinational drug firms such as Hoechst, Merck and Glaxo Wellcome are trying their best to manufacture drugs that keep cells from malfunctioning. This is done by blocking the signal that causes these cells to function errantly. The technology, called signal transcluction blocking, could prove invaluable for a host of ailments ranging from allergies, rheumatoid arthritis, osteoporosis to transplanted organ rejection. The biggest challenge is to design drugs that interfere with the process that makes proteins and hormones change shapes and bind, signalling a cell to act without blocking signals for needed activity by other cells.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.